ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $276,089 | +18.2% | 14,670 | 0.0% | 0.00% | – |
| Q4 2022 | $233,546 | -59.2% | 14,670 | -37.9% | 0.00% | -100.0% |
| Q1 2022 | $572,000 | +108.8% | 23,611 | +110.2% | 0.00% | 0.0% |
| Q2 2021 | $274,000 | +3.8% | 11,234 | +9.8% | 0.00% | 0.0% |
| Q1 2021 | $264,000 | -68.7% | 10,232 | -35.1% | 0.00% | -50.0% |
| Q4 2020 | $843,000 | +208.8% | 15,765 | +138.2% | 0.00% | +100.0% |
| Q3 2020 | $273,000 | -13.9% | 6,619 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $317,000 | -8.4% | 6,541 | -20.2% | 0.00% | -50.0% |
| Q1 2020 | $346,000 | -33.1% | 8,198 | -32.2% | 0.00% | 0.0% |
| Q4 2019 | $517,000 | +60.6% | 12,091 | +35.2% | 0.00% | +100.0% |
| Q3 2019 | $322,000 | -46.4% | 8,941 | -77.3% | 0.00% | -66.7% |
| Q2 2018 | $601,000 | -32.9% | 39,372 | -1.2% | 0.00% | -40.0% |
| Q1 2018 | $896,000 | -41.1% | 39,868 | -21.0% | 0.01% | -50.0% |
| Q4 2017 | $1,520,000 | -18.8% | 50,488 | -25.2% | 0.01% | -16.7% |
| Q3 2017 | $1,872,000 | +46.2% | 67,532 | +47.1% | 0.01% | +33.3% |
| Q2 2017 | $1,280,000 | -5.0% | 45,907 | -30.6% | 0.01% | -10.0% |
| Q1 2017 | $1,347,000 | +4.0% | 66,101 | -8.6% | 0.01% | -9.1% |
| Q4 2016 | $1,295,000 | -30.6% | 72,345 | -29.4% | 0.01% | -31.2% |
| Q3 2016 | $1,867,000 | -17.0% | 102,506 | -12.9% | 0.02% | -27.3% |
| Q2 2016 | $2,249,000 | +62.7% | 117,706 | +21.0% | 0.02% | +37.5% |
| Q1 2016 | $1,382,000 | -6.9% | 97,241 | +133.6% | 0.02% | -5.9% |
| Q4 2015 | $1,484,000 | +234.2% | 41,636 | +210.5% | 0.02% | +142.9% |
| Q3 2015 | $444,000 | – | 13,411 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |